In summary, our results indicate that MALAT1 could inhibit autophagic flux and instigate IL-6 via regulating PTEN/AKT/mTOR and SQSTM1/NF-κB pathways, which convert fibroblasts to CAFs to promote GC progression. Here, MTOR is linked to gastric cancer.